BridgeMD
New treatment option for Arthroplasty, Replacement, Knee
Official title BiFeS vs. iPACK in Postoperative Knee Arthroplasty Analgesia
ClinicalTrials.gov ID: NCT07360392
What this study is testing
- What it's testing
- The Biceps Femoris Short Head (BiFeS) block is a new fascial plane block technique targeting the sensory innervation of the posterolateral capsule of the knee while preserving motor function. The aim of this study is to evaluate the postoperative analgesic efficacy of the BiFeS block combined with the adductor canal block (ACB) in patients undergoing total knee arthroplasty, compared to ACB + iPACK block.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Scheduled for unilateral total knee arthroplasty
- Classified as ASA physical status I-III
You likely can't join if
- Scheduled for revision arthroplasty or bilateral surgery
- Allergy to local anesthetics or contraindication to regional blocks
- Neurological disorders, peripheral neuropathy, or conditions affecting lower extremity muscle strength
- Coagulopathy or receiving anticoagulant therapy
- History of severe liver, kidney, or heart failure
- Chronic opioid use or history of substance abuse
See the full eligibility criteria
- Scheduled for unilateral total knee arthroplasty
- Classified as ASA physical status I-III
- Scheduled for revision arthroplasty or bilateral surgery
- Allergy to local anesthetics or contraindication to regional blocks
- Neurological disorders, peripheral neuropathy, or conditions affecting lower extremity muscle strength
- Coagulopathy or receiving anticoagulant therapy
- History of severe liver, kidney, or heart failure
- Chronic opioid use or history of substance abuse
- Patients experiencing intraoperative complications (e.g., excessive bleeding)
- Cases in which adequate sensory blockade is not achieved after the block
The study team makes the final eligibility decision.
Where it's taking place
- Amasya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amasya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.